Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

Last updated: February 11, 2025
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasms

Peritoneal Cancer

Malignant Ascites

Treatment

Biological collection

Clinical Study ID

NCT03976999
ICM-BDD2016/04
2016-A01041-50
  • Ages > 18
  • All Genders

Study Summary

A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 or older

  • Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caneror a primitive peritoneal cancer

  • Patient eligible for, at least, one surgery and a chemotherapy

  • Patient having given his informed, written and express consent

Exclusion

Exclusion Criteria:

  • Patient not affiliated to a social protection scheme

  • Pregnant and / or nursing women

  • Subject under tutelage, curatorship or safeguard of justice

  • Patient whose regular follow-up is impossible for psychological, familial, social orgeographical reasons

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Biological collection
Phase:
Study Start date:
July 05, 2017
Estimated Completion Date:
July 31, 2032

Study Description

A Clinical and Biological Database is a collection of reliable, prospective and representative datas.

This collection, provided to the scientific community, will help to develope research programs such as :

  • Cinicals and biological predictive factors of treatments response

  • Identification of biological tumoral markers associate with survival

  • Identification of prognosic factors after recidivism

  • Diagnostics tests optimisation and follow-up from blood samples ( Circulating Tumor Cells (CTC) )

  • Developing strong preclinical models. Those models would be later used to test alternative treatments and would help to identify new biomarkers

Connect with a study center

  • ICM - Institut régional du Cancer Montpellier

    Montpellier, 34298
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.